Pulmonary invasive aspergillosis in patients infected with the human immunodeficiency virus: Report of two cases

Heart and Lung: Journal of Acute and Critical Care

Volumn 27, Issue 1, 1998, Pages 63-66

  Mylonakis, Eleftherios ^a,b,c   Mileno, Maria D ^a,b   Flanigan, Timothy ^a,b   De Orchis, Douglas F ^a,b   Rich, Josiah ^a,b  

^a Brown University School of Medicine ^*

^b BROWN UNIVERSITY   (United States)

^c MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; CD4 ANTIGEN;

ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; AUTOPSY; CASE REPORT; DYSPNEA; FEMALE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ASPERGILLOSIS; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; PROGNOSIS; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY;

EID: 0031892711     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9563(98)90071-1     Document Type: Article

References (26)

1. Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992;14(suppl 1):S43-53.
2. Klapholz A, Salomon N, Perlman DC, Talavera W. Aspergillosis in the acquired immunodeficiency syndrome. Chest 1991;100:1614-8.
3. Khoo SH, Denning DW. Invasive aspergillosis in patients with AIDS. Clin Infect Dis 1994;19(suppl 1):S41-8.
4. Chandler FW. Pathology of the mycoses in patients with the acquired immunodeficiency syndrome (AIDS). Curr Top Med Mycol 1985;1:1-23.
5. Lortholary O, Meyohas MC, Dupont B, Cadranel J, Salmon-Ceron D, Peyramond D, et al. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French cooperative study group on aspergillosis in AIDS. Am J Med 1993;95:177-87.
6. Levitz SM. Aspergillosis. Infect Dis Clin North Am 1989;3: 1-18.
7. Woods GL, Goldsmith JC. Aspergillus infection of the central nervous system in patients with acquired immunodeficiency syndrome. Arch Neurol 1990;47:181-4.
8. Mylonakis E, Rich JD, Flanigan T, Kwakwa H, De Orchis DF, Boyce J, et al. Muscle abscess due to Aspergillus fumigatus in a patient with AIDS. Clin Infect Dis 1996;23:1323-4.
9. Mylonakis E, Rich J, Skolnik PR, De Orchis DF, Flanigan T. Invasive Aspergillus sinusitis in HIV-infected patients: report of 2 cases and review. Medicine 1997;76:249-55.
10. Minamoto GA, Barlam TF, van der Els NJ. Invasive aspergillosis in patients with AIDS. Clin Infect Dis 1992;14:66-74.
11. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:654-62.
12. Logan PM, Primack SL, Staples C, Miller RR, Muller NL. Acute lung disease in the immunocompromised host: diagnostic accuracy of the chest radiograph. Chest 1995;108:1283-7.
13. Knani L, Maslo C, Lucet JC, Gachot B, Veder B, Lepretre A, et al. Overwhelming aspergillosis with positive blood cultures in an AIDS patient [abstract No. Pub 7286]. In: Program and abstracts of the VIII International Conference on AIDS; 1992 July; Amsterdam.
14. Duthie R, Denning DW. Aspergillus fungemia: report of two cases and review. Clin Infect Dis 1995;20:598-605.
15. Pursell KJ, Telzak EE, Armstrong D. Aspergillus species colonization invasive disease in patients with AIDS. Clin Infect Dis 1992;14:141-8.
16. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990;12:1027-34.
17. Lewin SR, Hoy J, Crowe SM, McDonald CF. The role of bronchoscopy in the diagnosis and treatment of pulmonary disease in HIV-infected patients. Aust N Z J Med 1995;25:133-9.
18. Mylonakis E, Chalevelakis G, Saroglou G, Danias P, Argyropoulou A, Paniara O, et al. Efficacy of deoxycholate amphotericin B and unilamellar liposomal amphotericin B in prophylaxis of experimental Aspergillus fumigatus endocarditis. Mayo Clin Proc 1997;72:1022-7.
19. Hiemenz JW, Walsh TJ. Lipid formulations of amphotericin B: recent progress and future directions. Clin Infect Dis 1996;22(suppl 2):S133-43.
20. White MH, Anaissie EJ, Kusne S, Wingard JR, Hiemenz JW, Cantor A, et al. Amphotericin B colloidal dispersion vs amphotericin B as therapy for invasive aspergillosis. Clin Infect Dis 1997;24:635-42.
21. Bohme A, Hoelzer D. Liposomal amphotericin B as early empiric antimycotic therapy of pneumonia in granulocytopenic patients. Mycoses 1996;39:419-26.
22. Shetty D, Giri N, Gonzalez CE, Pizzo PA, Walsh TJ. Invasive aspergillosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1997;16:216-21.
23. Vassiloyanakopoulos A, Mylonakis E, Butsikakis J, Kytea E, Argyropoulou AD, Lazanas M, et al. Therapeutic efficacy of amphotericin B and liposomal amphotericin B in the Aspergillus fumigatus rabbit endocarditis model [abstract no 422]. In: Program and abstracts of the 6th International Congress for Infectious Diseases; 1994 April; Prague.
24. Kauffman CA. Role of azoles in antifungal therapy. Clin Infect Dis 1996;22(suppl 2):S148-53.
25. Fairley CK, Kent SJ, Street A, Mijch A, Hoy J. Invasive aspergillosis in AIDS. Aust N Z J Med 1991;21:747-9.
26. Tumbarello M, Ventura G, Caldarola G, Morace G, Cauda R, Ortona L. An emerging opportunistic infection in HIV patients: a retrospective analysis of 11 cases of pulmonary aspergillosis. Eur J Epidemiol 1993;9:638-44.